UTILISATIONS DE MOLÉCULES CTLA4 MUTANTES
- 专利权人:
- Bristol-Myers Squibb Company
- 发明人:
- 申请号：
- EP18158752.8
- 公开号：
- EP3384924A1
- 申请日:
- 2001.07.02
- 申请国别(地区):
- EP
- 年份:
- 2018
- 代理人:
- 摘要：
- The present invention relates to soluble CTLA4 molecules for use in treating immune system diseases such as rheumatic diseases.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- Utilisations des molécules mutantes solubles CTLA4
- FUSION MOLECULES AND METHODS FOR TREATMENT OF IMMUNE DISEASES
- Fusion molecules and methods for treatment of immune diseases
- METHODS OF TREATING IMMUNE DISEASES IN CONNECTION WITH ORGAN TRANSPLANTATION WITH SOLUBLE, Mutating CTLA4 MOLECULES
- METHODS FOR TREATING CARDIOVASCULAR DISEASE USING A SOLUBLE CTLA4 MOLECULE
